Morgan Stanley Cuts Carlyle Group (NASDAQ:CG) Price Target to $66.00
Carlyle Group (NASDAQ:CG – Free Report) had its target price cut by Morgan Stanley from $71.00 to $66.00 in a research note published on Tuesday,Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock. Several other research analysts have also recently weighed in on the stock. Weiss Ratings reissued a […]
Domino’s Pizza (NASDAQ:DPZ) Price Target Lowered to $430.00 at Morgan Stanley
Domino’s Pizza (NASDAQ:DPZ – Get Free Report) had its price objective decreased by analysts at Morgan Stanley from $455.00 to $430.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the restaurant operator’s stock. Morgan Stanley’s price target points to a potential upside of 17.12% […]
Host Hotels & Resorts (NASDAQ:HST) Price Target Raised to $20.00 at Morgan Stanley
Host Hotels & Resorts (NASDAQ:HST – Get Free Report) had its target price increased by stock analysts at Morgan Stanley from $18.00 to $20.00 in a research report issued on Friday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 0.45% from […]
Morgan Stanley Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $185.00
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target boosted by stock analysts at Morgan Stanley from $173.00 to $185.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s price objective suggests a potential upside of 42.38% […]
Biogen (NASDAQ:BIIB) Price Target Raised to $200.00 at Morgan Stanley
Biogen (NASDAQ:BIIB – Get Free Report) had its target price upped by equities research analysts at Morgan Stanley from $190.00 to $200.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has an “equal weight” rating on the biotechnology company’s stock. Morgan Stanley’s target price points to a potential […]
last updated on 24 Apr 09:17